- Le Bihan D,
Breton E,
Lallemand D,
Aubin ML,
Vignaud J,
Laval-Jeantet M.
Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.
Radiology.
1988;168:497-505.
- Bisdas S.
Are we ready to image the incoherent molecular motion in our minds? Neuroradiology [Internet].
2013 May [cited 2014 Mar 2];55(5):537-40.
- Taouli B,
Thakur RK,
Mannelli L,
Babb JS,
Kim S,
Hecht EM,
et al.
Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.
Radiology 2009;251(2):398-407.
- Kim S,
Jain M,
Harris AB,
Lee VS,
Babb JS,
Sigmund EE,
et al.
T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast- enhanced MR imaging.
Radiology 2009;251(3):796-807.
5.
Inci E,
Hocaoglu E,
Aydin S,
Cimilli T.
Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification.
Eur J Radiol 2011.
6.
Wang H,
Cheng L,
Zhang X,
Wang D,
Guo A,
Gao Y,
et al.
Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
Radiology 2010;257(1):135-43.
7.
Schor-Bardach R,
Alsop DC,
Pedrosa I,
et al.
Does arterial spin-labeling MR imaging Y measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model? Radiology.
2009;251: 731-42.
8.
Sun MR,
Ngo L,
Genega EM,
et al.
Renal cell carcinoma: dynamic contrast- enhanced MR imaging for differentiation of tumor subtypes Vcorrelation with pathologic findings.
Radiology.
2009;250:793-802.
9.
Chandarana H,
Kang SK,
Wong S,
Rusinek H,
Zhang JL,
Arizono S,
et al.
Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation.
Invest.
Radiol.
2012 Dec;47(12):688-96.
10.
Barentsz JO,
Richenberg J,
Clements R,
Choyke P,
Verma S,
Villeirs G,
et al.
ESUR prostate MR guidelines 2012.
Eur.
Radiol.
2012 Apr; 22(4):746-57
11.
Gibbs P,
Tozer DJ,
Liney GP,
Turnbull LW.
Comparison of quantitative T2 mapping and diffusion- weighted imaging in the normal and pathologic prostate.
Magn Reson Med 2001; 46:1054-1058
12.
Issa B.
In vivo measurement of the apparent diffusion coefficient in normal and malignant prostate tissues using echo-planar imaging.
J Magn Reson Imaging 2002; 16:196-200
13.
Chan I,
Wells W 3rd,
Mulkern RV,
et al.
Detection of prostate cancer by integration of line-scan dif- fusion,
T2-mapping and T2-weighted MR imaging; a multichannel statistical classifier.
Med Phys 2003; 30:2390-98
14.
Sato C,
Naganawa S,
Nakamura T,
et al.
Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate.
J Magn Reson Imaging 2005; 21:258-62
15.
Quentin M,
Blondin D,
Klasen J,
Lanzman RS,
Miese F-R,
Arsov C,
et al.
Comparison of different mathematical models of diffusion-weighted prostate MR imaging.
Magn.
Reson.
Imaging ; 2012;30(10):1468-74.
16.
Le Bihan D,
Breton E,
Lallemand D,
Aubin ML,
Vignaud J,
Laval-Jeantet M.
Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.
Radiology 1988; 168:497-505
17.
Döpfert J,
Lemke A,
Weidner A,
Schad LR.
Investigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging.
Magn Reson Imaging 2011; 29:1053-1058
18.
Shinmoto H,
Oshio K,
Tanimoto A,
et al.
Biexponential apparent diffusion coefficients in prostate cancer.
Magn Reson Imaging 2009; 27:355-359
19.
Shinmoto H,
Tamura C,
Soga S,
Shiomi E,
Yoshihara N,
Kaji T,
et al.
An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer.
AJR.
Am.
J.
Roentgenol.
2012;199(4):W496-500.
20.
Liu X,
Peng W,
Zhou L,
Wang H.
Biexponential apparent diffusion coefficients values in the prostate: comparison among normal tissue,
prostate cancer,
benign prostatic hyperplasia and prostatitis.
Korean J.
Radiol.
2013;14(2):222–32.
21.
Review Role of diffusion-weighted imaging in the diagnosis of gynecological diseases.
Namimoto T,
Awai K,
Nakaura T,
Yanaga Y,
Hirai T,
Yamashita YEur Radiol.
2009 Mar; 19(3):745-60.
22.
Diffusion-weighted magnetic resonance imaging of uterine cervical cancer.
Liu Y,
Bai R,
Sun H,
Liu H,
Wang D J Comput Assist Tomogr.
2009 Nov-Dec; 33(6):858-62.
23.
Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer.
Kyriazi S,
Collins DJ,
Morgan VA,
Giles SL,
deSouza NM Radiographics.
2010 Sep; 30(5):1269-85.
24.
H.
Seki,
R.
Azumi,
and M.
Kimura,
“Stromal invasion by carcinoma of the cervix: assessment with dynamic MR imaging,” American Journal of Roentgenology 1997;168 (6):1579-85.
25.
H.Hricak,
P.
S.
Swift,Z.Campos,
J.M.
Quivey,V.Gildengorin,
and H.
Goranson,
“Irradiation of the cervix uteri: value of unenhanced and contrast-enhanced MR imaging,
Radiol 1993;189(2): 381-8.